• Users Online: 147
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2019| January-June  | Volume 5 | Issue 1  
    Online since July 22, 2019

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
LETTERS TO EDITOR
Drug-induced Henoch-Schonlein purpura with severe gastrointestinal involvement
Nibedita Dixit, Chinmoy Raj, Debasmita Behera, Maitreyee Panda
January-June 2019, 5(1):46-48
DOI:10.4103/ijdd.ijdd_24_19  
  1 1,509 62
BRIEF REPORT
Successful Treatment of Pyogenic Granuloma with Sclerotherapy
Neelima Bansal, Vasudha A Belgaumkar, Ravindranth B Chavan, Bhavana Ravindra Doshi
January-June 2019, 5(1):30-33
DOI:10.4103/ijdd.ijdd_6_19  
  - 1,350 80
CASE REPORTS
Sorafenib-Induced Cutaneous Toxicities: Four Different Presentations
Pooja Bains, Saurabh Sharma
January-June 2019, 5(1):34-37
DOI:10.4103/ijdd.ijdd_36_18  
  - 991 52
Thalidomide-induced leukocytoclastic vasculitis in leprosy
Vasudha Abhijit Belgaumkar, Pallavi Prataprao Patil, Ravindranath Brahmadeo Chavan, Prernaa R Suryataley
January-June 2019, 5(1):38-41
DOI:10.4103/ijdd.ijdd_14_19  
  - 463 49
“PRIDE” Complex: A Report of Two Cases
Shashank Krishna Agrawal, Bhagyashree Babanrao Supekar, Vaishali Wankhade, Rajesh Pratap Singh
January-June 2019, 5(1):42-45
DOI:10.4103/ijdd.ijdd_8_19  
  - 2,160 100
EDITORIAL
Biologics in psoriasis: Indian experience
Shrichand G Parasramani, Jisha Pillai
January-June 2019, 5(1):1-5
DOI:10.4103/ijdd.ijdd_33_19  
  - 4,908 468
LETTERS TO EDITOR
Drug-Induced Hypersensitivity Syndrome to Leflunomide
Dhanashree Santosh Bhide, Kiran Chartrabhuj Ardad, Jaismeen Kaur Arora
January-June 2019, 5(1):48-50
DOI:10.4103/ijdd.ijdd_22_19  
  - 621 41
A first case of late-onset imatinib mesylate-induced lichenoid drug eruption
Farhana I Khan, Girishkumar R Ambade, A G. Krishna Greeshma, Anand J Asia
January-June 2019, 5(1):51-54
DOI:10.4103/ijdd.ijdd_15_19  
  - 421 61
Delayed-onset serum sickness due to rituximab in pemphigus vulgaris
Ajay Deshpande
January-June 2019, 5(1):54-57
DOI:10.4103/ijdd.ijdd_5_19  
  - 410 47
Desloratadine induced headache: Are we noticing or missing it?
Harsimran Chawla, Mohammad Rafi, Chaitanya Namdeo, Chhaya Goyal
January-June 2019, 5(1):57-58
DOI:10.4103/ijdd.ijdd_18_19  
  - 583 32
Potassium iodide: A prodigy in the treatment of subcutaneous zygomycosis
Peela Nalini, Seethalakshmi Ganga Vellaisamy, Navakumar Manickam, Kannan Gopalan
January-June 2019, 5(1):59-62
DOI:10.4103/ijdd.ijdd_10_19  
  - 1,123 86
MANAGING A SIDE EFFECT
Managing a side effect: Cyclophosphamide-induced hemorrhagic cystitis
Bhavana Ravindra Doshi, Vijaya Veeranna Sajjan, BS Manjunathswamy
January-June 2019, 5(1):66-71
DOI:10.4103/ijdd.ijdd_31_19  
  - 3,152 266
ORIGINAL ARTICLES
Real-life efficacy and safety of secukinumab: A single-center, retrospective observational study with 52-week follow-up
Shekhar Neema, S Radhakrishnan, Sehdev Singh, Biju Vasudevan, Manas Chatterjee
January-June 2019, 5(1):14-18
DOI:10.4103/ijdd.ijdd_37_18  
  - 766 89
A comparative study between topical adapalene (0.1%) versus a combination of topical adapalene (0.1%) and intense pulsed light therapy in the treatment of inflammatory and noninflammatory facial acne vulgaris: A split-face randomized controlled trial
Shah Karan, Jadhav Vikrant, Gugle Anil
January-June 2019, 5(1):19-25
DOI:10.4103/ijdd.ijdd_28_18  
  - 1,282 83
Oral ranitidine: A promising novel therapeutic option in molluscum contagiosum in children
Pooja Agarwal, Bhushan Madke, Priyanka Bodar
January-June 2019, 5(1):26-29
DOI:10.4103/ijdd.ijdd_41_18  
  - 5,439 236
REVIEW ARTICLE
Janus Kinase Inhibitors in Dermatology
Aditya Kumar Bubna
January-June 2019, 5(1):6-13
DOI:10.4103/ijdd.ijdd_38_18  
  - 4,377 539
VIVA VOCE
Viva voce on apremilast
Uday S Khopkar, Kinjal Deepak Rambhia
January-June 2019, 5(1):63-65
DOI:10.4103/ijdd.ijdd_36_19  
  - 753 128
WHAT’S IN NEWS
News from regulatory corner: Safety communication and recent drug approvals
Manasi Shirolikar
January-June 2019, 5(1):72-74
DOI:10.4103/ijdd.ijdd_28_19  
  - 433 64